Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.

ABSTRACT:

Background

Immobilization of the lower limb is a risk factor for venous thromboembolism (VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in adult patients with lower-limb immobilization to prevent deep venous thrombosis (DVT) and its complications. This is an update of the review first published in 2008.

Objectives

To assess the effectiveness of low molecular weight heparin for the prevention of venous thromboembolism in patients with lower-limb immobilization in an ambulatory setting.

Search methods

For this update, the Cochrane Vascular Information Specialist searched the Specialised Register, CENTRAL, and three trials registers (April 2017).

Selection criteria

Randomized controlled trials (RCTs) and controlled clinical tri

SUBMITTER: Zee AA 

PROVIDER: S-EPMC6483324 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature